Alpine Immune Sciences

+$0.24 (+3.00%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALPN and other ETFs, options, and stocks.

About ALPN

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies.

CEO
Mitchell H. Gold
Employees
85
Headquarters
Seattle, Washington
Founded
2007

ALPN Key Statistics

Market cap
250.21M
Price-Earnings ratio
—
Dividend yield
—
Average volume
89.14K
High today
$8.29
Low today
$7.72
Open price
$8.12
Volume
68.78K
52 Week high
$14.40
52 Week low
$6.00

ALPN News

Simply Wall StMay 16

Insiders who bought in the last 12 months lose an additional US$65k as Alpine Immune Sciences, Inc. drops to US$229m

The recent 11% drop in Alpine Immune Sciences, Inc.'s ( ) stock could come as a blow to insiders who purchased US$268k worth of stock at an average buy price of

ALPN Earnings

-$0.55
-$0.37
-$0.18
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.19 per share
Actual
-$0.25 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure